Pinnacle Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pinnacle Private Wealth's BMY Position: Q2 2022 in Review
Pinnacle Private Wealth increased its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2022, buying an estimated $49.5K and bringing the position to 5,615 shares worth $432K. The position accounts for 0.17% of the portfolio, ranked #144.
Pinnacle Private Wealth first reported a position in BMY in Q4 2021 and has held it in 3 quarters since. 2,540 funds tracked by Wall St. Rank hold BMY as of Q2 2022.
- Pinnacle Private Wealth held 5,615 shares of Bristol-Myers Squibb worth $432K as of Q2 2022.
- Pinnacle Private Wealth bought 650 Bristol-Myers Squibb shares in Q2 2022, an estimated $49.5K.
- Bristol-Myers Squibb made up 0.17% of Pinnacle Private Wealth's portfolio in Q2 2022, its #144 holding.
- Pinnacle Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 3 quarters since.
- 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.
Based on Pinnacle Private Wealth's 13F filing for Q2 2022, filed 15 Jul 2022.